Melanotan I
Also known as: melanotan 1, mt-1, mt1, afamelanotide, scenesse
α-MSH analogue and melanocortin receptor agonist studied for skin tanning and photoprotection.
Quick Reference
Melanotan I - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Chemical compound
Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria, a rare form of genetic sun sensitivity. Afamelanotide is a melanocortin 1 receptor (MC1 receptor) agonist and a synthetic peptide and analogue of α-melanocyte stimulating hormone. It is administered as subcutaneous implant.
Mechanism of Action
Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria, a rare form of genetic sun sensitivity. Afamelanotide is a melanocortin 1 receptor (MC1 receptor) agonist and a synthetic peptide and analogue of α-melanocyte stimulating hormone. It is administered as subcutaneous implant.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Melanotan I (also known as melanotan 1, mt-1) is studied within the dermatology and hair growth research community. α-MSH analogue and melanocortin receptor agonist studied for skin tanning and photoprotection.
Last updated October 28, 2026
Research status: active. Melanotan I appears across dermatology and hair growth research forums and academic literature. Researchers note this compound falls in the hair skin category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Melanotan I. Comments are reviewed before appearing.